Dissemination of antibiotic resistance genes from antibiotic producers to pathogens

Xinglin Jiang, Mostafa M. Hashim Ellabaan, Pep Charusanti, Christian Munck, Kai Blin, Yaojun Tong, Tilmann Weber, Morten O. A. Sommer, Sang Yup Lee

Read Dissemination of antibiotic resistance genes from antibiotic producers to pathogens by Xinglin Jiang, Mostafa M. Hashim Ellabaan, Pep Charusanti, Christian Munck, Kai Blin, Yaojun Tong, Tilmann Weber, Morten O. A. Sommer, Sang Yup Lee in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5467266.txt.

Introduction

Jiang and co-authors test whether some drug resistance genes in disease bacteria came from the microbes that make antibiotics. Their research article appeared in Nature Communications. Antibiotic-producing soil bacteria carry genes that protect them from their own poisons. A long-standing idea held that pathogens borrowed those genes. Proof of the route was missing. The team combined computer analysis with lab experiments.

They found genes in proteobacteria, including some pathogens, that closely match resistance genes of the producers. The matches cover drugs of real clinical importance. Two cases look like recent transfers between the groups. The team then proposed a mechanism and tested it. A carrier DNA strand first moves from pathogen kin into a producer. It recombines there with the resistance gene. The pathogen group then takes the combined strand back up. Their results support both ancient and recent transfers of this kind.

Catalog record

CREATORXinglin Jiang, Mostafa M. Hashim Ellabaan, Pep Charusanti, Christian Munck, Kai Blin, Yaojun Tong, Tilmann Weber, Morten O. A. Sommer, Sang Yup Lee
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5467266

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Dissemination of antibiotic resistance genes from antibiotic producers to pathogens By Xinglin Jiang, Mostafa M. Hashim Ellabaan, Pep Charusanti, Christian Munck, Kai Blin, Yaojun Tong, Tilmann Weber, Morten O. A. Sommer, Sang Yup Lee Published in: Nature Communications DOI: 10.1038/ncomms15784 ABSTRACT It has been hypothesized that some antibiotic resistance genes (ARGs) found in pathogenic bacteria derive from antibiotic-producing actinobacteria. Here we provide bioinformatic and experimental evidence supporting this hypothesis. We identify genes in proteobacteria, including some pathogens, that appear to be closely related to actinobacterial ARGs known to confer resistance against clinically important antibiotics. Furthermore, we identify two potential examples of recent horizontal transfer of actinobacterial ARGs to proteobacterial pathogens. Based on this bioinformatic evidence, we propose and experimentally test a ‘carry-back' mechanism for the transfer, involving conjugative transfer of a carrier sequence from proteobacteria to actinobacteria, recombination of the carrier sequence with the actinobacterial ARG, followed by natural transformation of proteobacteria with the carrier-sandwiched ARG. Our results support the existence of ancient and, possibly, recent transfers of ARGs from antibiotic-producing actinobacteria to proteobacteria, and provide evidence for a defined mechanism. The discovery of antibiotics from microorganisms and their development into clinical drugs constitutes one of the greatest advances in medical history, but the acquisition and dissemination of genes that confer antibiotic resistance among pathogens has severely curtailed the effectiveness of many of these compounds. Elucidating the origins of these antibiotic resistance genes (ARGs) and the mechanisms mediating their spread to pathogens is consequently a public health priority1. Actinobacteria, especially of the genus Streptomyces, produce many clinically important antibiotics. In most cases, the gene clusters encoding the biosynthesis of these compounds also contain resistance genes as a self-protecting mechanism towards these compounds2 or to modulate their signalling activity3. As early as 1973, it was hypothesized that the enzymes found in Gram-negative pathogens that inactivate aminoglycoside antibiotics could have originated from the ARGs of actinobacteria that produce this class of antibiotics through ancient horizontal gene transfer (HGT), based on the discovery that they employ the same enzymatic mechanisms4. This ‘producer hypothesis' was subsequently proposed for additional ARGs, for example, some class-A β-lactamases5 in Gram-negative pathogens, and erythromycin6 and vancomycin resistance genes7 in Gram-positive pathogens. However, in these cases the sequence similarities between ARG proteins in actinobacteria and Gram-negative pathogens are low, making it difficult to distinguish if they result from ancient HGT or from other types of evolutionary processes8. Compared with ancient transfers, recent ARG dissemination from actinobacteria to pathogens may pose an even more urgent threat to human health9, as actinobacterial ARGs make up a large portion of the environmental resistome. In addition to self-protecting ARGs, most actinobacteria also carry ARGs horizontally obtained from other actinobacteria610. In an investigation of actinomycetes from soil, isolates were on average resistant towards seven to eight antibiotics from a collection of 21 representative antibiotics11. In a functional metagenomics study using Escherichia coli as an expression host, actinobacteria were found to be the most enriched source of resistance-conferring DNA fragments relative to their abundance12. However, since no recent transfer from actinobacteria to Gram-negative pathogens has been discovered and many recent studies showed that phylogenetic and ecological boundaries are two major ARG transfer barriers12131415, the clinical relevance of this large resistome remains unclear1617. Here, we examine a large collection of known Streptomyces ARGs, and find more examples supporting the ‘producer hypothesis'. Specifically, we provide evidence that two ARGs conferring resistance against chloramphenicol and lincomycin might have been recently transferred from actinobacteria to human and animal pathogens. Based on their surrounding sequence, we propose and test a potential mechanism mediating gene transfer from Gram-positive actinobacteria to Gram-negative pathogens. RESULTS Actinobacterial ARGs have related proteins in proteobacteria Proteobacteria encompass many important human pathogens such as Escherichia coli, Pseudomonas aeruginosa and others. We therefore sought to examine the similarity between corresponding ARGs in actinobacteria and proteobacteria. First, we extracted all experimentally validated Streptomyces ARG proteins from ARDB18 and CARD19 databases. A majority (39 of 57) of them are reported to have self-protecting roles or are located within antibiotic biosynthesis gene clusters as analysed by antiSMASH20 (Supplementary Data 1). Their most similar homologues in proteobacteria were subsequently identified from the NCBI non-redundant protein database by BLASTP, with sequence identities ranging from 23 to 68%. Seven of these proteobacterial proteins have sequences more similar to actinobacterial proteins than to proteins from any other phyla, including proteobacteria (Supplementary Data 1). Furthermore, phylogenetic trees were constructed and showed that 12 (including the above seven) of the proteobacterial proteins may have originated from actinobacteria by interphylum HGT (Fig. 1 and Supplementary Fig. 1)21. Potential HGTs in the opposite direction, from proteobacteria to actinobacteria, were also noticed in some trees. In particular, the Streptomyces ARG sul1 (AFN41071.1) shares 95% sequence identity with a proteobacterial gene (Supplementary Fig. 1). By examining neighbouring genes, we also found evidence for potential cotransfer of additional genes in the case of the ARG pac (conferring resistance to puromycin). The products of six neighbouring genes also show higher similarity to actinobacterial proteins than to proteins from any other phyla, suggesting that they might have been transferred together from actinobacteria to proteobacteria (Supplementary Fig. 2). Of the 12 proteobacterial proteins that might have originated from actinobacteria, nine are encoded in genomes of environmental species, one of which has close homologues encoded in the genomes of pathogens from the database PATRIC22. The other three proteins are harboured by pathogens, including the well-known aminoglycoside-inactivating phosphotransferase APH(3″) (WP_031942890.1)4. Recent ARG transfers from actinobacteria to proteobacteria By analysing DNA sequence composition signatures using RAIphy23, we found that two of the proteobacterial proteins, chloramphenicol exporter Cmx (WP_005297378.1) and lincomycin exporter LmrA (WP_038989331.1), may have been recently transferred from actinobacteria, since the proteobacterial genes still retain actinobacterial sequence signatures (Supplementary Data 2)8. Cmx is found in clinical isolates of P. aeruginosa, Klebsiella oxytoca and Enterobacter asburiae (Supplementary Data 3). It is 63% identical (100% coverage) to the chloramphenicol resistance protein (P31141) from Streptomyces lividans 66 (ref. 24), and 52% identical (99% coverage) to the self-protecting resistance protein (WP_015032122.1) from chloramphenicol producer Streptomyces venezuelae (Supplementary Fig. 3). Furthermore, its gene was found to be identical or almost identical (identity over 99%) to genes from many non-Streptomyces actinobacteria (Fig. 2), further supporting that the interphylum gene transfer happened recently. Possible mechanisms of the ARG transfers Conjugation or transduction from actinobacteria to proteobacteria has so far not been described. Many proteobacteria can take up free DNA through natural transformation, but because of low sequence similarity, actinobacterial DNA has a low probability of being incorporated into proteobacterial genomes by homologous recombination25. In theory, the DNA can be inserted randomly by non-homologous end joining, but the frequency is extremely low26. Transposase/integrase-mediated recombination after natural transformation is possible if a transposase or integrase is encoded in the DNA and can be expressed before the DNA is degraded27. We noticed that cmx is colocalized with an actinobacterial transposase gene tnp45 forming a transposon28, and the intact transposon can be found in both actinobacteria and proteobacteria (Fig. 2). Initially, we hypothesized that a DNA fragment containing the transposon released from dead actinobacteria could be taken up by proteobacteria, and the transposon could insert itself into the new genome by the activity of its transposase. To test

Read the complete text